Health Services Research
Latest posts by Health Services Research (see all)
- Personalizing Nursing Home Compare and the Discharge from Hospitals to Nursing Homes - Oct. 25, 2016
- Testing the Replicability of a Successful Care Management Program: Results from a Randomized… - Oct. 25, 2016
- Disparities in Diabetes Care Quality by English Language Preference in Community Health Centers - Oct. 21, 2016
- Access to Care for Medicare-Medicaid Dually Eligible Beneficiaries: The Role of State Medicaid… - Oct. 21, 2016
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: